Abstract
Synaptotagmin 1 acts as the Ca2+ sensor for synchronous neurotransmitter release; however, the mechanism by which it functions is not understood and is presently a topic of considerable interest. Here, we describe measurements on full-length membrane-reconstituted synaptotagmin 1 using site-directed spin labeling in which we characterize the linker region as well as the cis (vesicle membrane) and trans (cytoplasmic membrane) binding of its two C2 domains. In the full-length protein, the C2A domain does not undergo membrane insertion in the absence of Ca2+; however, the C2B domain will bind to and penetrate in trans to a membrane containing phosphatidylinositol 4,5 bisphosphate, even if phosphatidylserine (PS) is present in the cis membrane. In the presence of Ca2+, the Ca2+ binding loops of C2A and C2B both insert into the membrane interface; moreover, C2A preferentially inserts into PS-containing bilayers and will bind in a cis configuration to membranes containing PS even if a phosphatidylinositol 4,5 bisphosphate membrane is presented in trans. The data are consistent with a bridging activity for synaptotagmin 1 in which the two domains bind to opposing vesicle and plasma membranes. The failure of C2A to bind membranes in the absence of Ca2+ and the long unstructured segment linking C2A to the vesicle membrane indicates that synaptotagmin 1 could act to significantly shorten the vesicle-plasma membrane distance with increasing levels of Ca2+.
Significance
Synaptotagmin 1 acts as a calcium sensor for synchronous neuronal exocytosis; however, the molecular mechanism by which it functions is presently not understood. Using electron paramagnetic resonance spectroscopy and other biophysical methods, we provide evidence that the two C2 domains of full-length synaptotagmin 1 are configured to bridge between the vesicle and plasma membranes during neuronal fusion. In particular, the C2B domain of synaptotagmin 1 is directed toward membranes containing phosphatidylinositol 4,5 bisphosphate, whereas the C2A domain is directed toward membranes containing phosphatidylserine. This finding, together with the fact that the long juxta-membrane linker is unstructured, indicates that synaptotagmin 1 is configured to regulate the vesicle-plasma membrane distance upon activation by calcium.
Introduction
Neuronal exocytosis involves a highly coordinated series of molecular steps that result in the fusion of the synaptic vesicle with the presynaptic membrane and the release of the neurotransmitter into the synapse. The assembly of three soluble N-ethylmaleimide-sensitive factor attachment receptor proteins (SNAREs) into a four-helical bundle provides the energy to drive this fusion event (1, 2), but the sequence of the assembly of these SNAREs and the mechanism by which increased Ca2+ levels trigger SNARE assembly are not known. The three neuronal SNAREs include syntaxin 1A and SNAP25 in the plasma membrane and synaptobrevin in the vesicle membrane (3, 4, 5), and they appear to interact with and be regulated by Munc18, Munc13, and complexin (6, 7, 8, 9). The binding of Ca2+ to synaptotagmin 1 (Syt1) triggers synchronous neurotransmitter release and is the primary Ca2+ sensing protein in this system (10).
Syt1 is anchored to the synaptic vesicle membrane by a single transmembrane helix. As shown in Fig. 1, a long linker of ∼60 residues connects the transmembrane helix to two Ca2+ binding C2 domains that are connected by a short flexible six residue segment (11). The binding of Ca2+ to Syt1 increases the affinity of the C2 domains toward membranes containing negatively charged lipids and results in the interfacial insertion of the Ca2+ binding loops of the domains. In the absence of Ca2+, the C2A domain has no significant membrane affinity, although C2B has a weak affinity to membranes containing phosphatidylserine (PS) and a stronger affinity to membranes with phosphatidylinositol 4,5 bisphosphate (PIP2) (12). This Ca2+-independent binding mode of the C2B domain is mediated by its highly positively charged polybasic face (13).
In addition to binding membranes, Syt1 also shows an affinity toward SNAREs. Several different structural models for Syt1-SNARE interactions have been generated using NMR and modeling (14), crystallography (15, 16), and single molecule fluorescence resonance energy transfer (17). These models indicate that multiple Syt1-SNARE interactions are possible, but because they involve interactions with assembled SNARE complexes that represent a postfusion state (18), they do not reveal how Syt1 might regulate fusion. Moreover, Syt1-SNARE interactions appear to be weak and heterogeneous and are diminished or eliminated when ionic compositions resembling those in the cell are present (19). Under these same conditions, Ca2+-dependent interactions of Syt1 to membranes, particularly to membranes containing PIP2 or a combination of PS and PIP2, are maintained.
These observations suggest that although Syt1-SNARE interactions might help localize Syt1 near the SNAREs, they are unlikely to be directly responsible for Ca2+-mediated synchronous release. The most robust interactions appear to be to membranes, and a number of models have been proposed that involve the regulation of fusion through the membrane interactions of Syt1. For example, Syt1 has been found to demix PS from the bulk lipid and to alter the acyl chain order of the bilayer in a Ca2+-dependent manner (20). Acyl chain order has been shown to alter the structure of the SNAREs, and Syt1 has been shown to alter the orientation of the SNAREs in a Ca2+-dependent manner (21). These observations suggest a model in which Syt1 triggers fusion by acting through the membrane and placing the SNAREs in a fusion-competent state. Syt1 has also been shown to alter the curvature properties of bilayers, and in a second model, Syt1 is proposed to modify curvature in a Ca2+-dependent manner and act with the SNAREs to overcome the energetic barriers to fusion (22). Earlier work demonstrated that the two C2 domains of Syt1 have the capacity to bridge between two bilayers (23, 24), and there is evidence that Syt1 may act to significantly shorten the vesicle-plasma membrane distance in the presence of Ca2+ (25). This suggests a model in which changes in vesicle-plasma membrane distance might place the prefusion SNARE complex or its regulatory partners in an active configuration. Finally, a quite different model has been proposed that involves the oligomerization of the C2B domains of Syt1 to form a large ring. This ring acts to sterically block interactions between the synaptic vesicle and the plasma membranes, and the binding of Ca2+ to Syt1 results in the membrane insertion of the domains and the release of this steric inhibition (26).
The bulk of the structural work on Syt1 has been carried out on a soluble fragment of Syt1 containing its two C2 domains (sC2AB). In this work, we examine the configuration and membrane insertion of the C2A and C2B domains in the context of full-length Syt1 (fSyt1). We identify conditions that lead to a bridging between two bilayers by fSyt1, and we characterize interactions within the long juxta-membrane linker of Syt1. We find no evidence that Syt1 oligomerizes in its full-length membrane-associated form; however, Syt1 is ideally configured to regulate the vesicle-plasma membrane distance. In the absence of Ca2+, the C2B domain is likely to target the PIP2-containing plasma membrane, whereas the C2A domain is free in the synaptic space, along with 50 residues of the long juxta-membrane linker. In the presence of Ca2+, both domains insert into the bilayer. However, because their lipid preferences are different, the two domains are likely to bridge between the vesicle and plasma membranes, thereby shortening this interbilayer space.
Materials and Methods
Expression and purification of Syt1 constructs
The C2B plasmid was provided by Jose Rizo-Rey (Texas Southwestern Medical Center, Dallas, TX), and expression and purification of sC2AB (residues 136–421), C2B (residues 271–421), and fSyt1 (residues 1–421) from Rattus norvegicus was carried out as previously published (Fig. 1) (12, 27, 28). The native cysteine at residue 277 was mutated to an alanine, and sC2AB and sC2B were expressed using pGEX-KG constructs with N-terminal GST tags. For sedimentation assays, site E269 was mutated to a cysteine using Polymerase Incomplete Primer Extension (PIPE) site-directed mutagenesis to attach a fluorophore. The native cysteines (C73A, C74A, C76A, C78A, C82S, and C277S) were mutated in fSyt1 using the PIPE site-directed mutagenesis (28) and expressed in a pET-28a vector with an N-terminal HIS6-tag. For electron paramagnetic resonance (EPR) measurements, single cysteine mutations were introduced into the cysteine-free construct at the following positions: K86C, K90C, K95C, A123C, P136C, M173C, and V304C. Double mutants were introduced at sites K86C-P136C, P136C-L323C, M173C-V304C, M173C-L323C, and M173C-A395C. DNA sequencing for all mutations were verified by GENEWIZ DNA sequencing (South Plainfield, NJ).
The sC2AB and C2B constructs were expressed in BL21(DE3) cells (Invitrogen, Carlsbad, CA) and then purified using GST affinity chromatography. For NMR experiments, C2B was grown in minimal media with 15NH4Cl (Cambridge Isotope Laboratories, Andover, MA) as the sole nitrogen source. GST tags were removed via thrombin cleavage, and the protein constructs were further purified by ion-exchange chromatography to remove any additional protein or nucleic acid contamination. The C2B domain was further purified with a final round of gel filtration chromatography. For binding measurements, sC2AB was fluorophore labeled at room temperature by first incubating with a 10-fold excess of dithiothreitol for 2 h, desalting, labeling with Bodipy FL C1-IA for 2 h, and finally running the protein through a PD-10 column. Labeled protein was dialyzed against 12 L of 20 mM 3-(N-morpholino)propanesulfonic acid and 150 mM KCl (pH 7) to remove free label.
The fSyt1 construct was expressed in BL21(DE3)-RIL cells (Invitrogen) and purified in CHAPS (3-[(3-Cholamidopropyl)dimethylammonio]-1-propanesulfonate) using nickel affinity chromatography following a protocol described earlier (29). The fSyt1 was spin labeled with the thiol-specific spin label (1-oxy-2,2,5,5-tetramethylpyrrolinyl-3-methyl)methanethiosulfonate while bound to the nickel column overnight at 4°C. The His tag was removed via thrombin cleavage, and fSyt1 was further purified by ion-exchange chromatography to remove any additional protein or nucleic acid contaminants. fSyt1 was reconstituted into either palmitoyloleoylphosphatidylcholine (POPC)/cholesterol (Chol) (80:20) or POPC/palmitoyloleoylphosphatidylserine (POPS) (85:15) at a 1:200 protein to lipid ratio by dialysis in the presence of Bio-Beads (Bio-Rad Laboratories, Hercules, CA) into metal-free buffer. The purity of all constructs was verified by sodium dodecyl sulfate polyacrylamide gel electrophoresis and the ultraviolet absorbance ratio (260/280 nm). The protein concentration was determined from the absorbance at 280 nm. All lipids were obtained from Avanti Polar Lipids (Alabaster, AL).
Vesicle sedimentation binding assays
Sedimentation binding assays were performed as described previously (12, 30). In one assay, sucrose-loaded 100-nm large unilamellar vesicles (LUVs) were titrated into Bodipy-labeled sC2AB at a 2 nM concentration; in a second assay, the lipid concentration of LUVs was maintained at 1 mM, and ATP/Mg2+ or P2O74−/Mg2 were increased in concentration to determine their effect upon sC2AB binding. Protein and LUVs were incubated for 10 min, and the LUVs were pelleted at 100,000 × g at 20°C for 1 h. Unbound protein in the supernatant was measured from Bodipy fluorescence emission (480 nm excitation and 520 nm emission) using a FluorMax3 (HORIBA Jobin Yvon, Edison, NJ). Values were used to calculate the fraction of membrane-bound protein (fb), and the data were fit to the expression fb = K[L]/(1 + K[L]), where K is the reciprocal molar partition coefficient, and [L] is the accessible lipid concentration. A standard phosphate assay was used to determine lipid concentrations (31, 32).
Proton-nitrogen heteronuclear single quantum coherence NMR
NMR experiments were performed on a Bruker 600 MHz NMR spectrometer as described previously (12) but using a shorter construct containing residues 271–421 (C2B). The NMR spectrum from 400 μM C2B was titrated against IP3 or ATP/Mg2+. The protein was in NMR buffer (50 mM MES, 150 mM NaCl, 3 mM CaCl2, and 10% D2O (pH 6.3)) in Shigemi tubes, and the spectrum was acquired at 27°C for 2 h. New protein samples were used for each titration point to avoid precipitation of C2B. The NMR data were processed in NMRPipe (33), and the residue assignments were matched in Sparky from the Protein Data Bank NMR resonance assignments of C2B (Protein Data Bank [PDB]: 1K5W) (27, 34). Chemical shift analysis was performed using CCPN NMR Analysis V2 (35). To determine the apparent affinity of ATP and IP3 to C2B, chemical shifts for each residue were fit using a standard binding isotherm: y = a(bx(1 + bx). Images for the chemical shift and binding constants were plotted onto the C2B domain using Pymol (36).
Continuous wave EPR
Experiments were performed as stated previously on a CW X-Band EMX spectrometer (Bruker BioSpin, Billerica, MA) equipped with an ER 4123D dielectric resonator (28). All EPR spectra were recorded at room temperature with 100-G magnetic field sweep, 1-G modulation, and 2.0-mW incident microwave power. The measurements were performed on 6-μL samples in glass capillary tubes (0.60 mm inner diameter × 0.84 mm outer diameter round capillary; VitroCom, Mountain Lakes, NJ). The phasing, normalization, and subtraction of EPR spectra were performed using LabVIEW software provided by Dr. Christian Altenbach (University of California Los Angeles, Los Angeles, CA) or with in-lab software written by David Nyenhuis.
To assess the cis or trans binding of fSyt1, EPR spectra from R1-labeled fSyt1 were recorded in reconstituted proteoliposomes using either negatively charged (POPC/POPS (85:15)) or uncharged lipid compositions (POPC/Chol (80:20)). The protein was reconstituted at a protein/lipid ratio of 1:200 and measured at a concentration of 50 μM protein. To determine trans binding, LUVs containing charged lipids at a 10 mM concentration (POPC/POPS (90:10) or POPC/PIP2 (95:5)) were added to the reconstituted fSyt1. The EPR spectra were recorded in a metal-free state, in the presence of 1 mM Ca2+, after the addition ATP/Mg2+, and then after the addition of 4 mM EGTA. Progressive Power saturation of the EPR spectra was performed as described previously (28, 37). Samples were placed in gas-permeable TPX-2 capillaries, and each sample was run in the presence of air (O2) or Ni(II)EDDA to determine the membrane depth parameter, Φ. The spin label depth was estimated using the following expression: Φ = A[tanh(B(x − C)) + D], where x is the distance of the spin label from the phospholipid phosphate plane in the bilayer, and A, B, C, and D are empirically determined constants (28, 37).
Pulsed EPR
Experiments were performed on a Bruker Elexsys E580 EPR spectrometer running at Q-band using an EN5107D2 dielectric resonator. Measurements were performed on single- or double-labeled fSyt in 20% deuterated glycerol at a concentration of ∼100–200 μM using a 12-μL sample volume. Samples were run in a physiological buffer (25 mM HEPES and 150 mM KCl (pH 7.4)) with or without the addition of calcium, a high ionic strength buffer (25 mM HEPES and 300 mM KCl (pH 7.4)) or a low ionic strength buffer (25 mM HEPES, and 25 mM KCl (pH 7.4)). Samples were loaded into quartz capillaries of 1.5 ID × 1.8 OD 100 mm length, flash frozen in liquid nitrogen, and then run at 80 K. DEER data were collected using a dead-time free four-pulse sequence with 16-step phase cycling (one 16 ns π/2 and two 32 ns π observe pulses separated by a 32 ns π pump pulse) (38, 39). Pump and observe pulses were separated by 75 MHz. Deer Analysis 2015, or DD was used for the removal of the dipolar background from the raw DEER data, V(t)/V(0) (39, 40, 41, 42); Tikhonov regularization was used to extract distance distributions from the resulting form factors, F(t)/F(0) (38, 43).
Results
Polyelectrolytes at low mM concentrations interfere with the Ca2+-dependent binding of Syt1 C2AB to bilayers containing PS but not to membranes containing PIP2
Moderate levels of ATP interfere with the Ca2+-dependent binding of reconstituted fSyt1 to vesicles containing PS but not to vesicles containing PIP2 (44). To explore the effect of ATP on the membrane binding affinity of Syt1, we used the soluble fragment of sC2AB to quantitate the Ca2+-dependent binding of sC2AB to membranes using a vesicle sedimentation assay (30). The equilibrium binding of sC2AB in the presence of Ca2+ to membranes containing 15 mol percentage of POPS is shown in Fig. 2 a and yields a partition coefficient of ∼2.2 ± 0.4 × 104 M−1, indicating that 50% of the protein is membrane associated at an accessible lipid concentration of ∼50 μM. This is within the values obtained in previous sedimentation measurements (12). As seen in Fig. 2 a, the addition of 1 mM pyrophosphate (P2O74−/Mg2+) reduces the affinity of sC2AB ∼threefold, and the addition of 1 mM ATP/Mg2+ eliminates the membrane binding of sC2AB.
In Fig. 2 b, the effect of adding either ATP/Mg2+ or P2O74−/Mg2+ on the partitioning of sC2AB to POPC/POPS (85:15) LUVs was examined. We fixed the lipid concentration at 1 mM, which is sufficient to bind virtually all sC2AB (Fig. 2 a). As seen in Fig. 2 b, the membrane binding of sC2AB is eliminated by a few hundred μM ATP/Mg2+ or 2–3 mM P2O74−/Mg2+. However, when 1 mol percentage of PIP2 is added to the POPC/POPS mixture (red trace), ATP no longer displaces sC2AB from the membrane interface, even up to levels of 3 mM.
In the full-length protein, the membrane insertion of the C2 domains was examined by incorporating the spin-labeled R1 side chain into the first Ca2+ binding loop of either the C2A or C2B domains of membrane-reconstituted fSyt1. These loops are known to undergo Ca2+-dependent membrane insertion in sC2AB (45) as well as fSyt1 (28, 29), and Fig. 3 a shows the EPR spectra obtained from sites 173R1 and 304R1 when fSyt1 is reconstituted into membranes containing POPC/POPS (85:15). The dramatic broadening in the EPR line shape upon Ca2+ addition is due to insertion into the membrane environment, which limits the rate of interconversion between R1 rotamers (46, 47). Membrane insertion can also be confirmed by progressive power saturation of the EPR spectrum (48), in which membrane depths of the R1 side chain attached to sC2AB and fSyt1 have been obtained (see Table S1; (12, 28)).
The case shown in Fig. 3 a is likely to result from the binding of C2A and C2B to the same (cis) vesicle into which Syt1 is reconstituted. However, binding in trans to a second membrane vesicle can be observed if a negatively charged lipid is eliminated from the cis vesicle. When incorporated into uncharged vesicles, the EPR spectra show no evidence for a cis membrane insertion of C2A or C2B with or without Ca2+, and this lack of insertion is also evident from the power saturation of the EPR spectrum (see Table S1; Katti et al. (28)). However, when phosphatidylcholine (PC)/PS (85:15) vesicles are added to this suspension of neutral membranes containing labeled fSyt1 (Fig. 3 b), a Ca2+-dependent trans insertion is observed for both the C2A and C2B domains. The EPR spectra with Ca2+ in Fig. 3 b are virtually identical to those seen in Fig. 3 a. In this case, the addition of 1 mM ATP/Mg2+ reverses the trans insertion of fSyt1. When the target membrane contains PC/PIP2 (95:5) (Fig. 3 c), trans insertion also takes place upon Ca2+ addition, but insertion of the domains is not reversed by ATP/Mg2+. Unlike the case seen in Fig. 3 b, ATP cannot reverse the POPC/POPS membrane insertion seen in Fig. 3 a for C2A or C2B associating in a cis configuration. The inability to reverse this cis binding is likely due to a strong membrane affinity due to the locally high concentration of negatively charged lipid experienced by the C2 domains on their proximal surface. This suggests that the Ca2+-dependent membrane binding seen in Fig. 3 a for C2A and C2B is likely to be dominated by a cis interaction.
Polyelectrolytes associate strongly with the polybasic face of C2B
Why does ATP interfere with sC2AB membrane binding? In these experiments, the levels of ATP added are not sufficient to chelate the available Ca2+ (49). However, acidic contaminants such as nucleic acids are known to strongly associate with the C2B domain on its highly polybasic surface, and this contamination is well known to modify the behavior of C2B (24, 50). The inhibition of the Syt1 membrane interaction by ATP/Mg2+ and the ability of PIP2 to overcome this inhibition is likely due to a competition between ATP/Mg2+ and PIP2 for the polybasic face of C2B. Shown in Fig. 4 are chemical shift maps obtained from heteronuclear single quantum coherence spectra of C2B in the presence of either IP3 (the headgroup of PIP2) or ATP (Figs. S1–S3). The chemical shifts produced in C2B by either of these polyanions are localized in and near the polybasic face. Shown in Fig. 4 b are the relative affinities determined from the chemical shifts when either ATP or IP3 are titrated into C2B. The average affinities of IP3 were found to be ∼16 μM, whereas the affinities of ATP were ∼20-fold weaker or ∼320 μM. The construct used in these experiments is important because the affinity of IP3 measured here is substantially stronger than that reported earlier for a longer C2B fragment (12). The relative differences in affinity between IP3 and ATP are consistent with the observation that PIP2 can overcome the inhibition in Syt1 membrane binding produced by ATP.
The C2B domain prefers to bind in trans to a PIP2-containing bilayer, whereas C2A prefers to bind in cis to a PS-containing bilayer
The data in Fig. 3 demonstrate that both C2A and C2B have the ability to bridge to membranes containing PS or PIP2 when fSyt1 is reconstituted into neutral liposomes. However, a more realistic vesicle lipid composition would include negatively charged lipid in the cis membrane, which may inhibit the trans binding of the domains. To explore this possibility, we examined the ability of fSyt1 to penetrate membranes when different compositions of charged lipid are used for cis versus trans vesicles.
The EPR line shapes from 173R1 in C2A and 304R1 in C2B were shown previously to vary depending upon whether they bound to a PS- or PIP2-containing bilayer (12). Shown in Fig. 5 a are spectra from 173R1 to 304R1 for sC2AB in aqueous solution or when bound to PS- or PIP2-containing bilayers in the presence of Ca2+. The line shape for 173R1 is significantly different when associated with a PIP2-containing membrane than when bound to a PS-containing bilayer (see blue and red traces in inset, Fig. 5 a). This difference is due to the fact that site 173 on C2A does not associate as deeply into a PIP2-containing bilayer as it does into a PS-containing bilayer (a result that was previously verified using power saturation (12)). There is also a slight difference in the line shape from 304R1 in the first Ca2+ binding loop of C2B, but this difference is difficult to distinguish in noisier EPR spectra. The line shape difference for site 173R1 allows us to distinguish whether C2A is associating with a bilayer containing PIP2 or PS.
Shown in Fig. 5, b and c are EPR spectra obtained from 173R1 and 304R1 when fSyt1 is reconstituted into liposomes either with or without negatively charged POPS when vesicles containing either POPS or PIP2 are added to the reconstituted fSyt1. As seen in Fig. 5 b, in the absence of Ca2+ site 173R1 on C2A shows no evidence for membrane insertion when vesicles containing either POPS or PIP2 are added to the vesicle mixture. This is consistent with the data in Fig. 3 c, indicating that there is no membrane insertion of C2A to POPS-containing bilayers without Ca2+. The spectrum from 304R1 in the first binding loop of C2B also shows no evidence for membrane insertion into POPS-containing bilayers in the absence of Ca2+ (Fig. 5 b, inset, green trace); however, there is membrane insertion of this site when vesicles containing PIP2 are added to reconstituted fSyt1 vesicles (inset, red trace). Calcium-independent insertion is also observed when fSyt1 is present in a POPC/POPS bilayer (blue trace). The blue and red spectra are identical, and no insertion of C2B into a POPS-containing bilayer is observed in the absence of Ca2+, indicating that C2B will insert in trans into a PIP2-containing bilayer even when POPS is present in the proximal or cis membrane. This is consistent with previous measurements showing that the Ca2+-independent binding of C2B is much stronger to membranes containing PIP2 than membranes containing only PS (12). The plasma membrane is believed to contain high levels of PIP2 at the focal site of fusion (51), and these data indicate that C2B will not be free in solution or associated with the vesicle membrane but will preferentially associate with the plasma membrane in the low Ca2+ state before fusion.
In the presence of Ca2+, the C2A domain will associate in trans to PIP2-containing membranes if Syt1 is present in a neutral membrane. The EPR spectrum for this condition (Fig. 5 c, red trace, and also Fig. 3 c) resembles that for 173 shown in Fig. 5 a in the presence of PIP2. It will also associate in trans to a POPS-containing bilayer if present in a neutral bilayer (green trace). However, C2A will bind in a cis configuration if it is reconstituted into a POPS-containing membrane even when presented with a PIP2-containing vesicle (Fig. 5 c, blue trace). Thus, in fSyt1, C2A prefers a POPS-containing bilayer over a PIP2-containing bilayer. For C2B, the spectra in Fig. 5 c show that site 304R1 on the C2B domain undergoes trans interfacial insertion into either a POPS- or PIP2-containing bilayer in the presence of Ca2+ when reconstituted into POPC/Chol. Because the EPR line shapes from site 304R1 when bound to PIP2 or POPS are very similar (inset, Fig. 5 a), it is not possible to distinguish whether C2B is binding in cis or trans when fSyt1 is reconstituted into a POPS-containing membrane. The fact that C2B is attached in trans to the PIP2-containing bilayer in the absence of Ca2+ and the dramatically higher affinity of C2B for the PIP2-containing bilayer suggests that that C2B will remain attached to and insert into the PIP2-containing bilayer with increases in Ca2+. Because PIP2 is believed to reside primarily in the plasma membrane, the two domains are likely to bind to opposing bilayers.
Pulse EPR data indicate that well-defined orientations between C2A and C2B are not present in fSyt1
Distance measurements using double electron-electron resonance (DEER) were previously used to examine the relative orientations of C2A and C2B in the sC2AB fragment and demonstrated that a bridging of sC2AB between two bilayers by the domains was a likely orientation for the fragment (23). Here, we made several measurements to examine the relative orientations between C2A and C2B in the full-length protein under conditions that should encourage either cis or trans binding of the C2A and C2B domains according to the data in Fig. 5.
Shown in Fig. 6 a are DEER data obtained between sites 173R1 and 323R1 in C2A and C2B, respectively. As seen previously in sC2AB, the distributions obtained for the fSyt1 are broad and were fit in this case with a single Gaussian. Other data obtained between labels in C2A and C2B in the full-length protein also yield broad distances (Fig. S4). As found previously for the sC2AB domain, the data indicate that the C2 domains of Syt1 are flexibly linked and do not assume a well-defined orientation relative to each other in the full-length protein (23). For those conditions that can be compared, the heterogeneity in the previously determined structures for sC2AB is similar, within experimental error, to that for the distributions obtained from fSyt1.
The distances between C2A and C2B in the full-length protein were explored under conditions that should favor cis binding of both domains (blue trace), under conditions in which only the C2B domain should bind in trans to a PIP2 vesicle (magenta trace) and under conditions favoring a bridging or a mixture of cis and trans states (green trace). This is expected to change the relative orientations of the domains and hence the interspin distances between these labeled sites. As seen in Fig. 6 a, the shortest average distance was obtained under conditions in which C2B is attached in trans or when there is likely to be a bridging between two vesicles. The longest distance was obtained when C2A and C2B should both be bound in a cis configuration (blue). This is consistent with the distances expected between sites 173 and 323 when the domains are oriented either parallel or antiparallel to each other. Moreover, the distance difference between these two configurations is expected to be ∼9 Å, which approximates the difference seen in Fig. 6 a.
Oligomerization of the C2 domains of fSyt1 cannot be detected
It should be noted that for fSyt1, no dipolar interactions can be detected for single labeled sites in C2A or C2B, and the distance distributions shown in Fig. 6 a are not a result of oligomerization. Fig. 6 b shows the background corrected DEER data obtained for 304R1 and 173R1 in the full-length protein in the absence of Ca2+ when reconstituted into POPC/Chol at a relatively high protein/lipid ratio of 1:200. No significant dipolar interactions are detected for this single labeled site. Dimers or ring-like oligomers of Syt1 should produce signals corresponding to interspin distances of ∼40 Å, which is well within the range that can be distinguished here. The absence of any signal in this case indicates that oligomers are not significantly populated. If the protein were simply dimerized, the signal-to-noise in these data indicate that less than 5% of the protein would be present in this state. A number of lipid compositions and solution conditions were examined, and no evidence for oligomers could be detected by EPR using the full-length protein (see Fig. S5).
Intramoleular interactions in the linker are weak and driven by electrostatics
It has been proposed that oppositely charged segments on the juxta-membrane linker might interact electrostatically, thereby regulating the effective length of the linker (52). This interaction, labeled (i) in Fig. 6 c, was examined in fSyt1 by placing labels within these two regions at sites 86 and 136. The modulation depth of the DEER signal obtained for 86R1/136R1 at low ionic strength (red trace) is 8%, which is less than half of that expected for a stable interaction between these regions under the conditions of this experiment. As seen in the blue trace, the signal was virtually eliminated by running the experiment at a higher ionic strength. Although there is clearly an interaction between these domains in the full-length protein, these data indicate that the interaction is transient and electrostatic in origin.
Another interaction that can be detected is an interaction between the highly positively charged face of C2B with the negatively charged region in the linker, labeled (ii) in Fig. 6 c. The modulation depth resulting from this dipolar interaction is 4% and is also much less than that expected for a stable intramolecular interaction. This suggests that this interaction, like the interaction between oppositely charged segments of the linker, is weak and transient. We also ran control experiments under these conditions to ensure that single labeled sites in the linker did not give rise to strong DEER signals because of oligomerization. These data, as well as EPR spectra from the linker, suggest that the linker is largely monomeric and unstructured and that only a small region of the linker adjacent to the transmembrane segment is associated with the membrane interface (see Fig. S6; Table S2).
Discussion
Synchronous neurotransmitter release is mediated by Ca2+ binding to the C2A and C2B domains of Syt1. It is not presently clear how this binding event triggers the assembly of the SNAREs and the fusion of the synaptic vesicle with the plasma membrane. The Ca2+-dependent membrane insertion of the C2A and C2B domains is robust and persists under conditions in which the Syt1-SNARE interactions are weak or absent. For example, normal ionic strength and normal cellular levels of ATP/Mg2+ largely eliminate Syt1/SNARE interactions, which appear to be weak and heterogeneous. However, under the same conditions, the binding of Syt1 to bilayers containing PIP2 persists (19). As a result, a number of models have focused on the membrane interactions of the C2 domains of Syt1 as the mediators of membrane fusion.
The polybasic face of C2B is an important structural feature of Syt1, and it determines much of the behavior of the protein. It has been known for some time that isolation of C2B or sC2AB requires an additional ion-exchange step to remove acidic contaminants from the protein and that these contaminants will eliminate the membrane binding of C2B and promote aggregation of the domain (50). Charge mutations in the polybasic face of C2B dramatically alter the affinity of the domain toward membranes containing PIP2 (12) and also have effects on fusion in vivo (14). Here, the presence of polyelectrolytes such as ATP at normal cellular levels is found to interfere with the membrane binding of sC2AB (as shown in Fig. 2) and the membrane insertion of fSyt1 (as shown in Fig. 3); however, the presence of PIP2 in the membrane can overcome this inhibition toward binding and insertion. This is consistent with the data presented in Fig. 4, which show that the PIP2 headgroup has a much higher affinity for the polybasic face of C2B than does ATP. These results are also consistent with previous work using two-color confocal microscopy, showing that vesicles containing Syt1 will not attach to opposing vesicles in the presence of ATP unless PIP2 is present in the target membrane (44).
The data presented here examined the cis versus trans interactions of the C2A and C2B domains in membrane-reconstituted fSyt1. The ability to bind in trans appears to be due in part to the polybasic face of C2B and the lipid preferences of the two domains. In the absence of Ca2+, the C2A domain does not penetrate charged membrane interfaces, but the C2B domain will penetrate to an opposing lipid bilayer containing PIP2, even when Syt1 is reconstituted into a membrane containing POPS. This finding differs somewhat from results obtained using a confocal vesicle tethering assay in which no bridging is detected in the absence of Ca2+ (53). This difference is likely due to the fact that the present experiments are carried out at much higher accessible lipid concentrations, which would favor membrane association for the weaker Ca2+-independent binding mode of C2B. At the focal site of fusion, the plasma membrane is believed to achieve high levels of PIP2 during the priming events for fusion, perhaps in excess of 5% (51), and the local lipid concentrations are likely to be high. As a result, the C2B domain is expected to be bound to the plasma membrane in the prefusion state. In the presence of Ca2+, the C2A domain binds preferentially to PS-containing bilayers, and it penetrates preferentially into a cis membrane containing PS even when presented with a lipid vesicle containing PIP2.
The data presented here indicate that the long linker connecting C2A to the transmembrane helix in the synaptic vesicle is largely monomeric and unstructured. In previous work, the long linker connecting C2A and C2B to the membrane interface was reported to oligomerize (54). However, oligomerization of fSyt1 is dependent upon the detergent used for protein reconstitution. In the protocol employed here, the protein was reconstituted from CHAPS, which produces EPR spectra from the C2A and C2B domains that resemble those obtained for the sC2AB fragment (29). Using this protocol, minor levels of oligomerization within the linker region are observed. There is also no significant dimerization or oligomerization of the C2A or C2B domains of fSyt1 when membrane reconstituted. This suggests that the tendency of Syt1 to oligomerize in the full-length protein is at best very weak, a finding that is not consistent with models in which rings of oligomerized Syt1 provide a steric block to vesicle-plasma membrane fusion in the absence of Ca2+ (26).
When reconstituted using CHAPS, the only region of the linker that appears to be in membrane contact is the segment close to the transmembrane vesicle anchor (Table S2). Acylation may be present within the linker (55); however, the cysteines that may be modified lie in this membrane-associated region and are close to the transmembrane anchor. As a result, they would not be expected to alter the C-terminal side of the linker, and the majority of the linker encompassing perhaps as many as 50 residues is likely to lie in the aqueous phase in an unstructured state. Although we do not know the state of the SNAREs or their associated regulatory proteins before fusion, the long linker would allow the C2A and C2B domains to diffuse a significant distance from the vesicle membrane interface in the prefusion state. As shown in Fig. 7, this may allow C2B to interact with the PIP2-containing plasma membrane, whereas C2A remains free in the cytosol. This arrangement gives Syt1 the ability to regulate the vesicle-plasma membrane distance upon the addition of Ca2+. The addition of Ca2+ would insert the C2 domains and limit the plasma membrane-vesicle membrane distance to the dimension of the C2 domains (∼4–5 nm). This is in fact consistent with a fluorescence-based lifetime measurement, indicating that Ca2+ reduces membrane separation by 2–3 nm to a distance of ∼5 nm (25).
The back-to-back binding of the C2A and C2B domains to opposing bilayers such as that shown in Fig. 7 was proposed previously based upon EPR restraints (23) and later based upon NMR data (24). It also appears to be a feature of the C2B domain, which may bridge bilayers on its own because of a highly positively charged region that lies opposite the Ca2+ binding site (56). There is also support for this type of model in earlier work proposing that PIP2 directs Syt1 toward the plasma membrane (57) and appears to be required in the target membrane for fusion activity (58, 59).
Exactly how changing the intermembrane vesicle-plasma membrane distance might trigger fusion is unclear. The prefusion complex is likely to involve a number of proteins, including the target-SNAREs (t-SNAREs) in a prefusion state with Munc18 (60), complexin (61), and perhaps synaptobrevin. Synaptobrevin might either be partially associated to the N-terminal region of the t-SNAREs or be complexed with Munc18 as has been suggested for yeast SNAREs (62). This is likely to be a very crowded environment, and the shortening of this intermembrane distance may bring the appropriate components into contact to trigger SNARE assembly or might remove steric constraints on the assembly of the complex.
Author Contributions
S.B.N. and D.S.C. wrote the article. S.B.N., A.T., and D.S.C. designed the experiments. S.B.N. and A.T. carried out the work.
Acknowledgments
We thank Profs. Reinhard Jahn, Lukas Tamm, and members of their research groups for helpful discussions during the course of this work. We would also like to acknowledge David Nyenhuis for help acquiring and processing DEER data and Vanessa Bajik for assistance with the NMR experiments.
We would like to acknowledge the support of National Institutes of Health grant PO1 GM072694 (to D.S.C.).
Footnotes
Editor: David Thomas.
Supporting Material can be found online at https://doi.org/10.1016/j.bpj.2019.06.016.
Supporting Material
References
- 1.Fasshauer D., Sutton R.B., Jahn R. Conserved structural features of the synaptic fusion complex: SNARE proteins reclassified as Q- and R-SNAREs. Proc. Natl. Acad. Sci. USA. 1998;95:15781–15786. doi: 10.1073/pnas.95.26.15781. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 2.Sutton R.B., Fasshauer D., Brunger A.T. Crystal structure of a SNARE complex involved in synaptic exocytosis at 2.4 A resolution. Nature. 1998;395:347–353. doi: 10.1038/26412. [DOI] [PubMed] [Google Scholar]
- 3.Südhof T.C. Neurotransmitter release: the last millisecond in the life of a synaptic vesicle. Neuron. 2013;80:675–690. doi: 10.1016/j.neuron.2013.10.022. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 4.Tamm L.K., Crane J., Kiessling V. Membrane fusion: a structural perspective on the interplay of lipids and proteins. Curr. Opin. Struct. Biol. 2003;13:453–466. doi: 10.1016/s0959-440x(03)00107-6. [DOI] [PubMed] [Google Scholar]
- 5.Wickner W., Schekman R. Membrane fusion. Nat. Struct. Mol. Biol. 2008;15:658–664. doi: 10.1038/nsmb.1451. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 6.Jahn R., Fasshauer D. Molecular machines governing exocytosis of synaptic vesicles. Nature. 2012;490:201–207. doi: 10.1038/nature11320. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 7.McMahon H.T., Missler M., Südhof T.C. Complexins: cytosolic proteins that regulate SNAP receptor function. Cell. 1995;83:111–119. doi: 10.1016/0092-8674(95)90239-2. [DOI] [PubMed] [Google Scholar]
- 8.Südhof T.C., Rothman J.E. Membrane fusion: grappling with SNARE and SM proteins. Science. 2009;323:474–477. doi: 10.1126/science.1161748. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 9.Brose N. For better or for worse: complexins regulate SNARE function and vesicle fusion. Traffic. 2008;9:1403–1413. doi: 10.1111/j.1600-0854.2008.00758.x. [DOI] [PubMed] [Google Scholar]
- 10.Chapman E.R. How does synaptotagmin trigger neurotransmitter release? Annu. Rev. Biochem. 2008;77:615–641. doi: 10.1146/annurev.biochem.77.062005.101135. [DOI] [PubMed] [Google Scholar]
- 11.Huang H., Cafiso D.S. Conformation and membrane position of the region linking the two C2 domains in synaptotagmin 1 by site-directed spin labeling. Biochemistry. 2008;47:12380–12388. doi: 10.1021/bi801470m. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 12.Pérez-Lara Á., Thapa A., Jahn R. PtdInsP2 and PtdSer cooperate to trap synaptotagmin-1 to the plasma membrane in the presence of calcium. eLife. 2016;5:e15886. doi: 10.7554/eLife.15886. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 13.Kuo W., Herrick D.Z., Cafiso D.S. The calcium-dependent and calcium-independent membrane binding of synaptotagmin 1: two modes of C2B binding. J. Mol. Biol. 2009;387:284–294. doi: 10.1016/j.jmb.2009.01.064. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 14.Brewer K.D., Bacaj T., Rizo J. Dynamic binding mode of a synaptotagmin-1-SNARE complex in solution. Nat. Struct. Mol. Biol. 2015;22:555–564. doi: 10.1038/nsmb.3035. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 15.Zhou Q., Lai Y., Brunger A.T. Architecture of the synaptotagmin-SNARE machinery for neuronal exocytosis. Nature. 2015;525:62–67. doi: 10.1038/nature14975. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 16.Zhou Q., Zhou P., Brunger A.T. The primed SNARE-complexin-synaptotagmin complex for neuronal exocytosis. Nature. 2017;548:420–425. doi: 10.1038/nature23484. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 17.Choi U.B., Strop P., Weninger K.R. Single-molecule FRET-derived model of the synaptotagmin 1-SNARE fusion complex. Nat. Struct. Mol. Biol. 2010;17:318–324. doi: 10.1038/nsmb.1763. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 18.Pobbati A.V., Stein A., Fasshauer D. N- to C-terminal SNARE complex assembly promotes rapid membrane fusion. Science. 2006;313:673–676. doi: 10.1126/science.1129486. [DOI] [PubMed] [Google Scholar]
- 19.Park Y., Seo J.B., Jahn R. Synaptotagmin-1 binds to PIP(2)-containing membrane but not to SNAREs at physiological ionic strength. Nat. Struct. Mol. Biol. 2015;22:815–823. doi: 10.1038/nsmb.3097. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 20.Lai A.L., Tamm L.K., Cafiso D.S. Synaptotagmin 1 modulates lipid acyl chain order in lipid bilayers by demixing phosphatidylserine. J. Biol. Chem. 2011;286:25291–25300. doi: 10.1074/jbc.M111.258848. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 21.Kiessling V., Kreutzberger A.J.B., Tamm L.K. A molecular mechanism for calcium-mediated synaptotagmin-triggered exocytosis. Nat. Struct. Mol. Biol. 2018;25:911–917. doi: 10.1038/s41594-018-0130-9. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 22.Martens S., Kozlov M.M., McMahon H.T. How synaptotagmin promotes membrane fusion. Science. 2007;316:1205–1208. doi: 10.1126/science.1142614. [DOI] [PubMed] [Google Scholar]
- 23.Herrick D.Z., Kuo W., Cafiso D.S. Solution and membrane-bound conformations of the tandem C2A and C2B domains of synaptotagmin 1: evidence for bilayer bridging. J. Mol. Biol. 2009;390:913–923. doi: 10.1016/j.jmb.2009.06.007. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 24.Seven A.B., Brewer K.D., Rizo J. Prevalent mechanism of membrane bridging by synaptotagmin-1. Proc. Natl. Acad. Sci. USA. 2013;110:E3243–E3252. doi: 10.1073/pnas.1310327110. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 25.Lin C.C., Seikowski J., Walla P.J. Control of membrane gaps by synaptotagmin-Ca2+ measured with a novel membrane distance ruler. Nat. Commun. 2014;5:5859. doi: 10.1038/ncomms6859. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 26.Ramakrishnan S., Bera M., Rothman J.E. Synaptotagmin oligomers are necessary and can be sufficient to form a Ca2+ -sensitive fusion clamp. FEBS Lett. 2019;593:154–162. doi: 10.1002/1873-3468.13317. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 27.Fernandez I., Araç D., Rizo J. Three-dimensional structure of the synaptotagmin 1 C2B-domain: synaptotagmin 1 as a phospholipid binding machine. Neuron. 2001;32:1057–1069. doi: 10.1016/s0896-6273(01)00548-7. [DOI] [PubMed] [Google Scholar]
- 28.Katti S., Nyenhuis S.B., Igumenova T.I. Non-native metal ion reveals the role of electrostatics in synaptotagmin 1-membrane interactions. Biochemistry. 2017;56:3283–3295. doi: 10.1021/acs.biochem.7b00188. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 29.Nyenhuis S.B., Cafiso D.S. Choice of reconstitution protocol modulates the aggregation state of full-length membrane-reconstituted synaptotagmin-1. Protein Sci. 2018;27:1008–1012. doi: 10.1002/pro.3398. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 30.Buser C.A., McLaughlin S. Ultracentrifugation technique for measuring the binding of peptides and proteins to sucrose-loaded phospholipid vesicles. Methods Mol. Biol. 1998;84:267–281. doi: 10.1385/0-89603-488-7:267. [DOI] [PubMed] [Google Scholar]
- 31.Bartlett G.R. Phosphorus assay in column chromatography. J. Biol. Chem. 1959;234:466–468. [PubMed] [Google Scholar]
- 32.Pokorny A., Birkbeck T.H., Almeida P.F. Mechanism and kinetics of delta-lysin interaction with phospholipid vesicles. Biochemistry. 2002;41:11044–11056. doi: 10.1021/bi020244r. [DOI] [PubMed] [Google Scholar]
- 33.Delaglio F., Grzesiek S., Bax A. NMRPipe: a multidimensional spectral processing system based on UNIX pipes. J. Biomol. NMR. 1995;6:277–293. doi: 10.1007/BF00197809. [DOI] [PubMed] [Google Scholar]
- 34.Goddard T.D., Kneller D.G. University of California; San Francisco: 2008. SPARKY 3.https://www.cgl.ucsf.edu/home/sparky/ [Google Scholar]
- 35.Vranken W.F., Boucher W., Laue E.D. The CCPN data model for NMR spectroscopy: development of a software pipeline. Proteins. 2005;59:687–696. doi: 10.1002/prot.20449. [DOI] [PubMed] [Google Scholar]
- 36.DeLano W.L. Pymol: an open-source molecular graphics tool. CCP4 Newsletter On Protein Crystallography. 2002;40:82–92. [Google Scholar]
- 37.Frazier A.A., Roller C.R., Cafiso D.S. Membrane-bound orientation and position of the synaptotagmin I C2A domain by site-directed spin labeling. Biochemistry. 2003;42:96–105. doi: 10.1021/bi0268145. [DOI] [PubMed] [Google Scholar]
- 38.Lee J., Nyenhuis D.A., Tamm L.K. Structure of the Ebola virus envelope protein MPER/TM domain and its interaction with the fusion loop explains their fusion activity. Proc. Natl. Acad. Sci. USA. 2017;114:E7987–E7996. doi: 10.1073/pnas.1708052114. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 39.Pannier M., Veit S., Spiess H.W. Dead-time free measurement of dipole-dipole interactions between electron spins. J. Magn. Reson. 2000;142:331–340. doi: 10.1006/jmre.1999.1944. [DOI] [PubMed] [Google Scholar]
- 40.Jeschke G., Chechik V., Jung H. DeerAnalysis2006 - a comprehensive software package for analyzing pulsed ELDOR data. Appl. Magn. Reson. 2006;30:473–498. [Google Scholar]
- 41.Jeschke G., Polyhach Y. Distance measurements on spin-labelled biomacromolecules by pulsed electron paramagnetic resonance. Phys. Chem. Chem. Phys. 2007;9:1895–1910. doi: 10.1039/b614920k. [DOI] [PubMed] [Google Scholar]
- 42.Stein R.A., Beth A.H., Hustedt E.J. A straightforward approach to the analysis of double electron-electron resonance data. Methods Enzymol. 2015;563:531–567. doi: 10.1016/bs.mie.2015.07.031. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 43.Polyhach Y., Bordignon E., Jeschke G. Rotamer libraries of spin labelled cysteines for protein studies. Phys. Chem. Chem. Phys. 2011;13:2356–2366. doi: 10.1039/c0cp01865a. [DOI] [PubMed] [Google Scholar]
- 44.Park Y., Hernandez J.M., Jahn R. Controlling synaptotagmin activity by electrostatic screening. Nat. Struct. Mol. Biol. 2012;19:991–997. doi: 10.1038/nsmb.2375. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 45.Herrick D.Z., Sterbling S., Cafiso D.S. Position of synaptotagmin I at the membrane interface: cooperative interactions of tandem C2 domains. Biochemistry. 2006;45:9668–9674. doi: 10.1021/bi060874j. [DOI] [PubMed] [Google Scholar]
- 46.Freed D.M., Khan A.K., Cafiso D.S. Molecular origin of electron paramagnetic resonance line shapes on β-barrel membrane proteins: the local solvation environment modulates spin-label configuration. Biochemistry. 2011;50:8792–8803. doi: 10.1021/bi200971x. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 47.Kroncke B.M., Horanyi P.S., Columbus L. Structural origins of nitroxide side chain dynamics on membrane protein α-helical sites. Biochemistry. 2010;49:10045–10060. doi: 10.1021/bi101148w. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 48.Altenbach C., Greenhalgh D.A., Hubbell W.L. A collision gradient method to determine the immersion depth of nitroxides in lipid bilayers: application to spin-labeled mutants of bacteriorhodopsin. Proc. Natl. Acad. Sci. USA. 1994;91:1667–1671. doi: 10.1073/pnas.91.5.1667. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 49.Bers D.M., Patton C.W., Nuccitelli R. A practical guide to the preparation of Ca(2+) buffers. Methods Cell Biol. 2010;99:1–26. doi: 10.1016/B978-0-12-374841-6.00001-3. [DOI] [PubMed] [Google Scholar]
- 50.Ubach J., Lao Y., Rizo J. The C2B domain of synaptotagmin I is a Ca2+-binding module. Biochemistry. 2001;40:5854–5860. doi: 10.1021/bi010340c. [DOI] [PubMed] [Google Scholar]
- 51.James D.J., Khodthong C., Martin T.F. Phosphatidylinositol 4,5-bisphosphate regulates SNARE-dependent membrane fusion. J. Cell Biol. 2008;182:355–366. doi: 10.1083/jcb.200801056. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 52.Lai Y., Lou X., Shin Y.K. The synaptotagmin 1 linker may function as an electrostatic zipper that opens for docking but closes for fusion pore opening. Biochem. J. 2013;456:25–33. doi: 10.1042/BJ20130949. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 53.Vennekate W., Schröder S., Walla P.J. Cis- and trans-membrane interactions of synaptotagmin-1. Proc. Natl. Acad. Sci. USA. 2012;109:11037–11042. doi: 10.1073/pnas.1116326109. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 54.Lu B., Kiessling V., Cafiso D.S. The juxtamembrane linker of full-length synaptotagmin 1 controls oligomerization and calcium-dependent membrane binding. J. Biol. Chem. 2014;289:22161–22171. doi: 10.1074/jbc.M114.569327. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 55.Heindel U., Schmidt M.F., Veit M. Palmitoylation sites and processing of synaptotagmin I, the putative calcium sensor for neurosecretion. FEBS Lett. 2003;544:57–62. doi: 10.1016/s0014-5793(03)00449-6. [DOI] [PubMed] [Google Scholar]
- 56.Xue M., Ma C., Rizo J. The Janus-faced nature of the C(2)B domain is fundamental for synaptotagmin-1 function. Nat. Struct. Mol. Biol. 2008;15:1160–1168. doi: 10.1038/nsmb.1508. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 57.Bai J., Tucker W.C., Chapman E.R. PIP2 increases the speed of response of synaptotagmin and steers its membrane-penetration activity toward the plasma membrane. Nat. Struct. Mol. Biol. 2004;11:36–44. doi: 10.1038/nsmb709. [DOI] [PubMed] [Google Scholar]
- 58.Wang Z., Liu H., Chapman E.R. Reconstituted synaptotagmin I mediates vesicle docking, priming, and fusion. J. Cell Biol. 2011;195:1159–1170. doi: 10.1083/jcb.201104079. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 59.Kreutzberger A.J.B., Kiessling V., Tamm L.K. Reconstitution of calcium-mediated exocytosis of dense-core vesicles. Sci. Adv. 2017;3:e1603208. doi: 10.1126/sciadv.1603208. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 60.Jakhanwal S., Lee C.T., Jahn R. An activated Q-SNARE/SM protein complex as a possible intermediate in SNARE assembly. EMBO J. 2017;36:1788–1802. doi: 10.15252/embj.201696270. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 61.Zdanowicz R., Kreutzberger A., Cafiso D.S. Complexin binding to membranes and acceptor t-SNAREs explains its clamping effect on fusion. Biophys. J. 2017;113:1235–1250. doi: 10.1016/j.bpj.2017.04.002. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 62.Baker R.W., Jeffrey P.D., Hughson F.M. A direct role for the Sec1/Munc18-family protein Vps33 as a template for SNARE assembly. Science. 2015;349:1111–1114. doi: 10.1126/science.aac7906. [DOI] [PMC free article] [PubMed] [Google Scholar]
Associated Data
This section collects any data citations, data availability statements, or supplementary materials included in this article.